Type ? Target CD22 CAS Number 1313706-14-7 | Source Humanized (from mouse) ATC code none ChemSpider none | |
Pinatuzumab vedotin is a monoclonal antibody designed for the treatment of B-cell malignancies.
This drug was developed by Genentech/Roche.
References
Pinatuzumab vedotin Wikipedia(Text) CC BY-SA